Maya Ballis, PHARMD
Ambulatory Care · Santa Clara
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Maya Ballis’s office at (408) 851-3923 to ask if they take your plan before you enroll.
California Medical Board record
Licence G77435 · Cancelled
Licence status: Cancelled · since 1993 · University of New Mexico School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$225,676
Pharmacies billed $225,676 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,364) in 2024. At or below the middle of the specialty; the typical pharmacist clinician is at 0%.
807 generic and 446 brand-name prescriptions · $225,676 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 122 | $90,290 | $740 |
| Jardiance | 81 | $51,420 | $635 |
| Insulin Glargine-Yfgn | 60 | $12,383 | $206 |
| Humulin N | 68 | $10,838 | $159 |
| Victoza 2-Pak | 15 | $9,424 | $628 |
See all 26 drugs
| Ozempic | 122 | $90,290 | $740 |
| Jardiance | 81 | $51,420 | $635 |
| Insulin Glargine-Yfgn | 60 | $12,383 | $206 |
| Humulin N | 68 | $10,838 | $159 |
| Victoza 2-Pak | 15 | $9,424 | $628 |
| Victoza 3-Pak | 12 | $9,105 | $759 |
| Humulin R | 43 | $7,426 | $173 |
| Humalog Kwikpen U-100 | 13 | $5,781 | $445 |
| Humulin N Kwikpen | 15 | $3,793 | $253 |
| Atorvastatin | 169 | $2,088 | $12 |
| Veo Insulin | 50 | $1,466 | $29 |
| Glipizide | 104 | $1,434 | $14 |
| Metformin Hcl Er | 128 | $1,277 | $10 |
| Glipizide Er | 39 | $1,134 | $29 |
| Metformin | 79 | $1,077 | $14 |
| Lisinopril | 51 | $615 | $12 |
| Ultra-Fine Nano Pen Needle | 24 | $578 | $24 |
| Losartan | 35 | $522 | $15 |
| Amlodipine Besylate | 34 | $423 | $12 |
| Simvastatin | 29 | $338 | $12 |
| Glimepiride | 20 | $260 | $13 |
| Hydrochlorothiazide | 19 | $255 | $13 |
| Rosuvastatin | 21 | $245 | $12 |
| Lisinopril-Hydrochlorothiazide | 20 | $243 | $12 |
| Ultra-Fine Mini Pen Needle | 11 | $233 | $21 |
| Atenolol | 13 | $152 | $12 |
Year by year
| 2024 | 1,364 | 279 | 0% (0) | 33% | $225,676 |
| 2023 | 1,392 | 283 | 0% (0) | 26% | $220,449 |
| 2022 | 1,908 | 327 | 0% (0) | 25% | $239,068 |
| 2021 | 1,957 | 286 | 0% (0) | 22% | $195,963 |
| 2020 | 1,825 | 276 | 0% (0) | 18% | $144,711 |
| 2019 | 2,013 | 464 | 0% (0) | 15% | $114,130 |
| 2018 | 382 | 131 | 0% (0) | 29% | $20,554 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 30 drugs
| Jardiance | 66 | $66,670 | $1,010 |
| Victoza 3-Pak | 21 | $38,186 | $1,818 |
| Victoza 2-Pak | 28 | $31,766 | $1,135 |
| Humulin N | 102 | $17,812 | $175 |
| Ozempic | 14 | $10,945 | $782 |
| Humulin N Kwikpen | 32 | $6,764 | $211 |
| Humulin R | 40 | $6,501 | $163 |
| Humalog | 12 | $5,524 | $460 |
| Humalog Kwikpen U-100 | 12 | $3,186 | $266 |
| Atorvastatin | 198 | $2,847 | $14 |
| Veo Insulin | 59 | $1,987 | $34 |
| Metformin Hcl Er | 149 | $1,484 | $10 |
| Glipizide | 106 | $1,403 | $13 |
| Metformin | 87 | $1,209 | $14 |
| Ultra-Fine Nano Pen Needle | 38 | $791 | $21 |
| Amlodipine Besylate | 57 | $770 | $14 |
| Glipizide Er | 17 | $644 | $38 |
| Losartan | 41 | $642 | $16 |
| Lisinopril | 52 | $620 | $12 |
| Pioglitazone | 24 | $475 | $20 |
| Ultra-Fine Mini Pen Needle | 17 | $459 | $27 |
| Simvastatin | 34 | $397 | $12 |
| Ultra-Fine Short Pen Needle | 12 | $372 | $31 |
| Veo Insulin | 12 | $322 | $27 |
| Glimepiride | 13 | $218 | $17 |
| Lovastatin | 17 | $212 | $12 |
| Hydrochlorothiazide | 14 | $190 | $14 |
| Lisinopril-Hydrochlorothiazide | 15 | $182 | $12 |
| Rosuvastatin | 11 | $179 | $16 |
| Atenolol | 14 | $177 | $13 |
2022: 31 drugs
| Jardiance | 99 | $96,784 | $978 |
| Victoza 2-Pak | 26 | $26,699 | $1,027 |
| Humulin N | 137 | $22,067 | $161 |
| Humulin R | 83 | $12,511 | $151 |
| Lantus Solostar | 21 | $11,443 | $545 |
| Humalog Kwikpen U-100 | 25 | $11,403 | $456 |
| Humulin N Kwikpen | 42 | $9,429 | $224 |
| Lantus | 19 | $5,866 | $309 |
| Humalog | 13 | $4,784 | $368 |
| Atorvastatin | 263 | $3,486 | $13 |
| Glipizide | 177 | $2,323 | $13 |
| Metformin Hcl Er | 205 | $2,068 | $10 |
| Veo Insulin | 61 | $1,769 | $29 |
| Metformin | 118 | $1,511 | $13 |
| Lisinopril | 92 | $1,147 | $12 |
| Ultra-Fine Mini Pen Needle | 28 | $951 | $34 |
| Amlodipine Besylate | 71 | $942 | $13 |
| Ultra-Fine Nano Pen Needle | 30 | $929 | $31 |
| Glipizide Er | 18 | $894 | $50 |
| Veo Insulin | 22 | $794 | $36 |
| Losartan | 47 | $735 | $16 |
| Simvastatin | 52 | $607 | $12 |
| Pioglitazone | 27 | $560 | $21 |
| Pravastatin | 12 | $517 | $43 |
| Lisinopril-Hydrochlorothiazide | 28 | $380 | $14 |
| Atenolol | 27 | $352 | $13 |
| Rosuvastatin | 25 | $345 | $14 |
| Hydrochlorothiazide | 26 | $343 | $13 |
| Veo Insulin | 13 | $330 | $25 |
| Glimepiride | 21 | $285 | $14 |
| Lovastatin | 21 | $272 | $13 |
2021: 27 drugs
| Jardiance | 61 | $54,800 | $898 |
| Humulin N | 151 | $26,315 | $174 |
| Lantus | 25 | $16,933 | $677 |
| Lantus Solostar | 22 | $15,788 | $718 |
| Humulin R | 70 | $14,019 | $200 |
| Humalog Kwikpen U-100 | 29 | $13,948 | $481 |
| Humalog | 24 | $12,520 | $522 |
| Humulin N Kwikpen | 30 | $7,689 | $256 |
| Atorvastatin | 279 | $3,727 | $13 |
| Veo Insulin | 99 | $2,681 | $27 |
| Glipizide | 164 | $2,349 | $14 |
| Metformin Hcl Er | 202 | $2,017 | $10 |
| Metformin | 136 | $1,772 | $13 |
| Lisinopril | 114 | $1,390 | $12 |
| Amlodipine Besylate | 79 | $1,049 | $13 |
| Ultra-Fine Mini Pen Needle | 26 | $1,012 | $39 |
| Veo Insulin | 25 | $906 | $36 |
| Losartan | 61 | $832 | $14 |
| Hydrochlorothiazide | 48 | $590 | $12 |
| Simvastatin | 46 | $537 | $12 |
| Atenolol | 39 | $460 | $12 |
| Lisinopril-Hydrochlorothiazide | 32 | $397 | $12 |
| Rosuvastatin | 27 | $368 | $14 |
| Glimepiride | 24 | $323 | $13 |
| Pioglitazone | 15 | $301 | $20 |
| Veo Insulin | 12 | $269 | $22 |
| Lovastatin | 19 | $242 | $13 |
2020: 25 drugs
| Humulin N | 129 | $26,500 | $205 |
| Lantus | 30 | $24,703 | $823 |
| Jardiance | 28 | $19,471 | $695 |
| Humulin R | 64 | $14,863 | $232 |
| Humalog | 22 | $11,566 | $526 |
| Humulin N Kwikpen | 26 | $7,808 | $300 |
| Humalog Kwikpen U-100 | 13 | $7,003 | $539 |
| Atorvastatin | 302 | $4,752 | $16 |
| Glipizide | 178 | $2,640 | $15 |
| Veo Insulin | 90 | $2,126 | $24 |
| Metformin | 145 | $1,935 | $13 |
| Metformin Hcl Er | 154 | $1,585 | $10 |
| Lisinopril | 97 | $1,189 | $12 |
| Losartan | 77 | $1,038 | $13 |
| Amlodipine Besylate | 75 | $969 | $13 |
| Simvastatin | 65 | $759 | $12 |
| Veo Insulin | 19 | $702 | $37 |
| Hydrochlorothiazide | 51 | $634 | $12 |
| Lisinopril-Hydrochlorothiazide | 41 | $524 | $13 |
| Atenolol | 39 | $408 | $10 |
| Ultra-Fine Mini Pen Needle | 13 | $316 | $24 |
| Pioglitazone | 16 | $307 | $19 |
| Lovastatin | 21 | $259 | $12 |
| Glimepiride | 19 | $255 | $13 |
| Rosuvastatin | 12 | $199 | $17 |
2019: 26 drugs
| Humulin N | 131 | $24,569 | $188 |
| Humulin R | 60 | $12,872 | $215 |
| Lantus | 16 | $12,169 | $761 |
| Humalog | 17 | $10,018 | $589 |
| Humalog Kwikpen U-100 | 18 | $8,643 | $480 |
| Atorvastatin | 348 | $8,319 | $24 |
| Humulin 70-30 | 20 | $6,313 | $316 |
| Glipizide | 204 | $3,032 | $15 |
| Metformin | 166 | $2,283 | $14 |
| Veo Insulin | 98 | $2,203 | $22 |
| Lisinopril | 144 | $1,810 | $13 |
| Metformin Hcl Er | 133 | $1,484 | $11 |
| Losartan | 91 | $1,173 | $13 |
| Simvastatin | 76 | $904 | $12 |
| Amlodipine Besylate | 71 | $833 | $12 |
| Hydrochlorothiazide | 68 | $784 | $12 |
| Glipizide Er | 11 | $695 | $63 |
| Glimepiride | 48 | $682 | $14 |
| Atenolol | 54 | $623 | $12 |
| Lisinopril-Hydrochlorothiazide | 44 | $589 | $13 |
| Veo Insulin | 17 | $543 | $32 |
| Pioglitazone | 26 | $511 | $20 |
| Rosuvastatin | 19 | $463 | $24 |
| Metoprolol | 31 | $395 | $13 |
| Lovastatin | 25 | $316 | $13 |
| Losartan-Hydrochlorothiazide | 13 | $188 | $14 |
2018: 12 drugs
| Humulin N | 35 | $5,132 | $147 |
| Humulin R | 11 | $2,582 | $235 |
| Atorvastatin | 49 | $1,332 | $27 |
| Glipizide | 35 | $682 | $19 |
| Veo Insulin | 23 | $549 | $24 |
| Metformin | 30 | $433 | $14 |
| Metformin Hcl Er | 28 | $428 | $15 |
| Glimepiride | 23 | $330 | $14 |
| Lisinopril | 19 | $232 | $12 |
| Losartan | 16 | $196 | $12 |
| Hydrochlorothiazide | 13 | $145 | $11 |
| Atenolol | 12 | $143 | $12 |
Professional record
- NPI
- 1730665407
- Licence
- CA 77435California G77435: Cancelled
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 1835P2201X (1835P2201X)
- Mailing address
- 501 J St, Sacramento, CA, 95814
- NPI first listed
- 2018-07-16
- NPI last updated
- 2021-11-29
- NPI record certified
- 2021-11-29
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.